|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2017011724066N2 |
|
Date of registration:
|
2017-01-28 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Compare Craving (Craving Beliefs) among patients of treated with Patients treated with buprenorphine maintenance, methadone maintenance treatment and tincture of opium
|
|
Scientific title:
|
Compare Craving (Craving Beliefs) among patients of treated with Patients treated with buprenorphine maintenance, methadone maintenance treatment and tincture of opium |
|
Date of first enrolment:
|
2017-01-01 |
|
Target sample size:
|
75 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/20406 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
|
Phase:
|
3
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr Hassan Azhdaei Zarmehri
|
|
Address:
|
Torbat Heydariyeh University of Medical Sciences, Next to the post office, Razi Street
Torbat Heydariyeh
Iran (Islamic Republic of) |
|
Telephone:
|
+98 51 5222 6011 |
|
Email:
|
hasan.azhdari@gmail.com |
|
Affiliation:
|
Torbat Heydariyeh University of Medical Sciences |
|
|
Name:
|
Dr Hassan Azhdari Zarmehri
|
|
Address:
|
Torbat Heydariyeh University of Medical Sciences, Next to the post office, Razi Street
Torbat Heydariyeh
Iran (Islamic Republic of) |
|
Telephone:
|
+98 51 5222 6011 |
|
Email:
|
hasan.azhdari@gmail.com |
|
Affiliation:
|
Torbat Heydariyeh University of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion criteria: Diagnosis of opioid dependence according to DSM-5 criteria; Lack of physical diseases; Lack of exposure to acute mental disorders; Having Between 20 and 60 years
Exclusion criteria: Re-drug use (relapse); Unwillingness to participate in the scheme
Exclusion criteria:
Age minimum:
20 years
Age maximum:
60 years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Mental and behavioural disorders due to use of opioids
|
Substance abuse.
Mental and behavioural disorders due to use of opioids
|
|
Intervention(s)
|
|
Intervention 1: Buprenorphine maintenance, for a period of two months, sublingual tablets, 1 or 2 times a day between 2 and 6 mg. Intervention 2: Methadone maintenance, syrups and tablets, 1 and 2 times a day from 25 mg to 120 mg can. Intervention 3: tincture of opium , syrup, according to 25 cc , 2 times a day.
|
|
Treatment - Drugs
|
|
Buprenorphine maintenance, for a period of two months, sublingual tablets, 1 or 2 times a day between 2 and 6 mg
|
|
tincture of opium , syrup, according to 25 cc , 2 times a day
|
|
Methadone maintenance, syrups and tablets, 1 and 2 times a day from 25 mg to 120 mg can
|
|
Primary Outcome(s)
|
|
Craving. Timepoint: Before the intervention, about one month during the first intervention, after intervention. Method of measurement: Craving Beliefs Questionnaire of Beck.
|
|
Source(s) of Monetary Support
|
|
Research Assistant of Torbat Heydariyeh University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Ethics Committee of the Torbat Heydariyeh University of Medical Sciences
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|